Navigation Links
Dr. Malgorzata Borowiak returns to the MDC from Harvard
Date:9/29/2011

This press release is available in German.

Dr. Malgorzata Borowiak, a researcher in the Department of Stem Cell and Regenerative Biology at Harvard University in Cambridge, MA, USA, has been awarded a grant from the Helmholtz Association to return to the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, as head of a Young Investigators Group. At the MDC, which is a member of the Helmholtz Association, Dr. Borowiak aims to contribute to diabetes research by studying the molecular basis of beta cell development. These cells, which produce insulin, a hormone essential for life, are defective in diabetics. Dr. Borowiak will also cooperate with Charit - Universittsmedizin Berlin.

Dr. Borowiak holds a Master's degree in Biotechnology from Adam Mickiewicz University in Poznań, Poland and completed her doctoral work under the supervision of Professor Carmen Birchmeier (MDC/Freie Universitt Berlin). She received her PhD degree in 2006 and then went to the U.S. for her postdoctoral work.

Altogether, this year the Helmholtz Association awarded Young Investigator grants to twenty early-stage researchers, ten of whom are women. They were selected from 226 applicants. With an annual budget of "at least 250, 000 euros over a period of five years and the prospect of gaining a tenure-track position", these grants, according to the Helmholtz Association, "are an ideal entry into a scientific career and are therefore attractive both for foreign applicants and for researchers who wish to return to Germany from a research stay abroad."

Half of the money will come from the Initiative and Networking Fund of the President of the Helmholtz Association and the other half from the research center at which the leader of the Young Investigators Group will work. Currently there are seven Helmholtz Young Investigators Groups at the MDC, including Dr. Borowiak's group.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. Science returns to the Capitol Hill spotlight at March 24 exhibition
2. Science returns to Capitol Hill spotlight at April 14 exhibition
3. The LouseBuster returns
4. VIMS team returns to Antarctic Peninsula
5. Oldest known wild bird in US returns to Midway to raise chick
6. Research ship Polarstern returns from Antartica
7. Organizational Change Management for Sustainability: The Harvard Case Study
8. Harvard scientist says we are what we eat -- and what we cook
9. Duke, Harvard researchers to monitor bonobo reintroduction
10. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
11. Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: